Ubs Group Ag Liva Nova PLC Transaction History
Ubs Group Ag
- $528 Billion
- Q1 2025
A detailed history of Ubs Group Ag transactions in Liva Nova PLC stock. As of the latest transaction made, Ubs Group Ag holds 745,400 shares of LIVN stock, worth $32.2 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
745,400
Previous 797,369
6.52%
Holding current value
$32.2 Million
Previous $36.9 Million
20.71%
% of portfolio
0.01%
Previous 0.01%
Shares
33 transactions
Others Institutions Holding LIVN
# of Institutions
266Shares Held
55.2MCall Options Held
72.5KPut Options Held
65.6K-
Black Rock Inc. New York, NY6.9MShares$299 Million0.01% of portfolio
-
Primecap Management CO Pasadena, CA4.61MShares$199 Million0.15% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.67MShares$115 Million0.0% of portfolio
-
State Street Corp Boston, MA2.1MShares$90.8 Million0.0% of portfolio
-
Capital Research Global Investors Los Angeles, CA2.08MShares$89.9 Million0.02% of portfolio
About LivaNova PLC
- Ticker LIVN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 53,545,700
- Market Cap $2.32B
- Description
- LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines,...